Skip to content

Clinical study for degenerative dementia

Clinical study for degenerative dementia - Degenerative dementia clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014098
Enrollment
150
Registered
2014-06-01
Start date
2014-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corticobasal syndrome, Primary progressive aphasia, Dementia with Lewy bodies

Interventions

Neuropshychological tests and Dopamine transporter scan

Sponsors

Juntendo University school of Medicine Department of Diagnosis, Prevention and Treatment of Dementia
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. corticobasal syndrome (CBS,J Neurol Neurosurg Psychiatry. 2012;83(4):405) 1. Mandatory criteria 1-1 Insidious onset and gradual progression 1-2 No sustained response to levodopa treatment 2. Major and minor criteria 2-1 Motor features Akinetic rigid syndrome Focal or segmental myoclonus Asymmetrical dystonia 2-2 Cortical motor sensory features Limb apraxia Alien limb phenomenon Cortical sensory loss or dyscalculia 2-3 Cognitive features Speech and language impairment Frontal executive dysfunction Visuospatial deficits 2. Dementia with Lewy bodies (DLB, Neurology 2005;65;1863) 1. Central feature Dementia defined as progressive cognitive decline of sufficient magnitude to interfere with normal social or occupational function. Deficits on tests of attention, executive function, and visuospatial ability may be especially prominent. 2. Core features (two core features are sufficient for a diagnosis of probable DLB, one for possible DLB) 2-1 Fluctuating cognition with pronounced variations in attention and alertness 2-2 Recurrent visual hallucinations that are typically well formed and detailed 2-3 Spontaneous features of parkinsonism 3. Suggestive features (If one or more of these is present in the presence of one or more core features, a diagnosis of probable DLB can be made. In the absence of any core features, one or more suggestive features is sufficient for possible DLB. Probable DLB should not be diagnosed on the basis of suggestive features alone.) 3-1 REM sleep behavior disorder 3-2 Severe neuroleptic sensitivity 3-3 Low dopamine transporter uptake in basal ganglia demonstrated by SPECT or PET imaging 3. Primary progressive aphasia (PPA, Neurology 2011;76:1006) 1. Most prominent clinical feature is difficulty with language 2. These deficits are the principal cause of impaired daily living activities 3. Aphasia should be the most prominent deficit at symptom onset and for the initial phases of the disease

Exclusion criteria

Exclusion criteria: 1) Cognitive dysfunction, systemic diseases or central nervous system other than CBS, PPA, and DLB (Schizophrenia, Bipolar disorder, Parkinson's disease, Vascular dementia, Huntington disease, brain tumor, Pick disease, Creutzfeldt-Jakob disease,Normal pressure hydrocephalus, Progressive supranuclear palsy,cerebral stroke, subdural hematoma, multiple sclerosis, epilepsy, HIV infection, neurosyphilis) 2. In the presence of any other physical illness such as Vitamine deficiency 3. In case physicians judge that the participants are mismatched.

Design outcomes

Primary

MeasureTime frame
Dopamine transporter scan

Secondary

MeasureTime frame
Neurospychological battery

Countries

Japan

Contacts

Public ContactYumiko Motoi

Juntendo University school of Medicine Department of Diagnosis, Prevention and Treatment of Dementia

motoi@juntendo.ac.jp+81-3-5689-8556

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026